Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 440Rectal Neoplasms 209Colonic Neoplasms 201Pancreatic Neoplasms 131Stomach Neoplasms 116Neoplasm Metastasis 97Neoplasms 63Esophageal Neoplasms 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Lymphoma 49Leukemia 41Carcinoma, Hepatocellular 40Adenocarcinoma Of Esophagus 37Burkitt Lymphoma 33Adenocarcinoma 29Cholangiocarcinoma 26Biliary Tract Neoplasms 22Carcinoma, Non-Small-Cell Lung 21Gastrointestinal Neoplasms 20Lymphoma, Non-Hodgkin 19Gallbladder Neoplasms 19Esophageal Squamous Cell Carcinoma 15Osteosarcoma 14Bile Duct Neoplasms 14Unspecified Adult Solid Tumor, Protocol Specific 13Lymphoma, Large B-Cell, Diffuse 13Liver Neoplasms 13Leukemia, Biphenotypic, Acute 13Ovarian Neoplasms 12Leukemia, Myeloid, Acute 12

Interventions

Surveys and Questionnaires 4pazopanib 3Erlotinib Hydrochloride 3Cetuximab 3Vorinostat 2Oxaliplatin 2Bevacizumab 2Azacitidine 2temsirolimus 1satraplatin 1ridaforolimus 1ixazomib 1X-Rays 1Videotape Recording 1Valproic Acid 1Trastuzumab 1Sugars 1Sorafenib 1Platinum 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Leucovorin 1Lenalidomide 1Lapatinib 1LY 2275796 1Injections, Subcutaneous 1Fluorouracil 1Everolimus 1Curcumin 1Crizotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Cancers × Leucovorin × Clear all
NCT00941499 2015-11-18

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

M.D. Anderson Cancer Center

Phase 1 Completed
140 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡